Correlation Between Editas Medicine and Caribou Biosciences
Can any of the company-specific risk be diversified away by investing in both Editas Medicine and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Editas Medicine and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Editas Medicine and Caribou Biosciences, you can compare the effects of market volatilities on Editas Medicine and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Editas Medicine with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Editas Medicine and Caribou Biosciences.
Diversification Opportunities for Editas Medicine and Caribou Biosciences
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Editas and Caribou is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Editas Medicine and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and Editas Medicine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Editas Medicine are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of Editas Medicine i.e., Editas Medicine and Caribou Biosciences go up and down completely randomly.
Pair Corralation between Editas Medicine and Caribou Biosciences
Given the investment horizon of 90 days Editas Medicine is expected to under-perform the Caribou Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Editas Medicine is 1.36 times less risky than Caribou Biosciences. The stock trades about -0.13 of its potential returns per unit of risk. The Caribou Biosciences is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 299.00 in Caribou Biosciences on August 24, 2024 and sell it today you would lose (101.00) from holding Caribou Biosciences or give up 33.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Editas Medicine vs. Caribou Biosciences
Performance |
| Timeline |
| Editas Medicine |
| Caribou Biosciences |
Editas Medicine and Caribou Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Editas Medicine and Caribou Biosciences
The main advantage of trading using opposite Editas Medicine and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Editas Medicine position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.| Editas Medicine vs. ZyVersa Therapeutics | Editas Medicine vs. Sonnet Biotherapeutics Holdings | Editas Medicine vs. Zura Bio Limited | Editas Medicine vs. Phio Pharmaceuticals Corp |
| Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| CEOs Directory Screen CEOs from public companies around the world |